Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer
| Field | Value |
|---|---|
| Model ID | 12-040-01 |
| Model Name | Romond 2012 |
| Pubmed ID | 22987084 |
| First Author | Romond |
| Journal | Journal of Clinical Oncology |
| Year | 2012 |
| Title | Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer |
| Primary Index Condition | Cancer |
| Secondary Index Condition | N/A |
| Outcome | MACE |
| Model Sample Size | 1830 |
| Cohort Sample Size | 1830 |
| Number of Events | 47 |
| Follow-Up Duration | Long (>6 months) |
| AUROC | 0.72 |
| Calibration Reported | 1 |
| Covariates | Age in years; Baseline percent LVEF |
| Mesh Terms | To be updated |
| Number of Validations | 0 |